Skip to main content
AVECHO BIOTECHNOLOGY LIMITED logo

AVECHO BIOTECHNOLOGY LIMITED — Investor Relations & Filings

Ticker · AVE ISIN · AU0000047441 LEI · 529900FA9G9T82C2LV25 ASX Manufacturing
Open in API
Filings indexed 881 across all filing types
Latest filing 2014-07-10 Capital/Financing Update
Country AU Australia
Listing ASX AVE

About AVECHO BIOTECHNOLOGY LIMITED

https://avecho.com.au/

Avecho Biotechnology Limited develops and commercializes human and animal health products using its proprietary drug delivery system, Tocopheryl Phosphate Mixture (TPM®). Derived from Vitamin E, TPM® is designed to enhance the solubility and absorption of active ingredients through the skin and digestive tract. The company focuses on applying this technology to pharmaceuticals, nutraceuticals, and animal health sectors. A primary area of development includes medicinal cannabis, where Avecho has produced high-bioavailability cannabidiol (CBD) softgel capsules for therapeutic use. The company’s portfolio also includes applications in pain management and dermatology, leveraging TPM® to improve the delivery of poorly soluble molecules and enhance the efficacy of existing treatments.

Recent filings

Filing Released Lang Actions
POH - SPP - Notice Under ASIC Class Order 09-425 1
Capital/Financing Update Classification · 95% confidence The document is a short company announcement dated 11 July 2014 from Phosphagenics Limited regarding a Share Purchase Plan notice under ASIC Class Order 09/425. It states the company will make offers to issue shares under the plan without disclosure under Part 6D.2 of the Corporations Act 2001. The document is brief (1353 characters) and serves as a regulatory notice about upcoming share issuance, not a detailed report or financial statement. It does not contain financial data or detailed analysis, nor is it a report publication announcement. The content fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising or capital structure changes such as share purchase plans.
2014-07-10 English
Trading Halt 3 pages 188.0KB
Regulatory Filings Classification · 95% confidence The document is a market release dated 9 July 2014 from Phosphagenics Limited announcing a Trading Halt on its securities pending a forthcoming announcement related to funding. The text explicitly states the securities will be halted until the earlier of normal trading resumption or the release of a significant funding announcement. There is no financial data, report, or detailed analysis included. The document is short (4148 characters) and serves as a notification to the market rather than a report or detailed filing. This fits the definition of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2014-07-08 English
Strengthens Partnership with Le Metier de Beaute Cosmetics 2 pages 45.3KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Phosphagenics Limited regarding the continuation and strengthening of a partnership with a cosmetics brand following an asset sale. It discusses business developments, partnership details, and forward-looking statements but does not contain financial statements, audit information, or detailed financial results. The document is relatively short (5423 characters) and serves as a corporate update rather than a formal financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Audit Report. It is also not a call transcript, capital update, or legal proceeding report. The content is best classified as a general regulatory announcement about business developments, which fits the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other specific categories.
2014-06-11 English
Appendix 3B Notice - Issue of Options to Directors 13 pages 313.7KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3B notice, which is a standard form used on the Australian Securities Exchange (ASX) for announcements related to the issue of new securities, including options and shares. The text details the issue of non-quoted options to directors, referencing shareholder approval at the 2014 Annual General Meeting. It includes specifics about the securities issued, exercise price, expiry date, and compliance with ASX rules. There are no financial statements or detailed financial performance data, nor is this a report or presentation. It is a formal announcement of a capital change (issue of securities). Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief report publication announcement or a regulatory filing. Confidence is high due to the clear identification of the document as an Appendix 3B new issue announcement.
2014-06-02 English
Appendix 3Y Notices -3- Change in Directors Interest 10 pages 238.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notices' and contains detailed disclosures of changes in securities holdings by company directors, specifically the issuance of non-quoted options to directors following shareholder approval at the 2014 Annual General Meeting. It references compliance with ASX Listing Rule 3.19A.2 and the Corporations Act section 205G, which govern director's interest disclosures. The content is focused on personal share transactions by directors, including number of securities held before and after, nature of the change, and consideration details. There is no financial performance data, earnings information, or management discussion. The document is not an announcement of a report but a direct filing of director share transactions. Therefore, it fits the definition of Director's Dealing (DIRS).
2014-06-02 English
2014 AGM Addresses - Presentations 24 pages 1.1MB
AGM Information Classification · 95% confidence The document is titled 'Annual General Meeting 2014' and contains multiple presentations given at the AGM, including the Chairman's Address and CEO Address. The content focuses on speeches and presentations made during the AGM event held on 23 May 2014. There is no indication that this is the full Annual Report or financial statements, but rather materials shared at the AGM. The length is substantial (15,000 characters), consistent with detailed AGM presentations. Therefore, this document fits the category of AGM Information (AGM-R).
2014-05-22 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.